"Le Centre Hospitalier Régional Sambre et Meuse (CHRSM) est le groupement hospitalier de deux institutions : le CHRSM – site Meuse à Namur et le CHRSM – site Sambre à Auvelais. Le CHRSM est un acteur majeur en Province de Namur. Avec près de 700 lits agréés, ce sont plus de 3.000 collaborateurs, dont 380 médecins, qui peuvent prendre en charge la plupart des pathologies, avec une qualité de soins toujours plus élevée en plaçant le patient au centre de leurs préoccupations. Le CHRSM prend soin de ses valeurs d’Humanité, d’Écoute, d’Excellence, d’Engagement et d’Esprit d’équipe. Des valeurs qui le caractérisent et le font avancer jour après jour, comme le montre les investissements toujours plus nombreux dans son infrastructure et son per"

During the past decade, CHR Namur conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHR Namur" #1 sponsor was "Jules Bordet Institute" with 3 trials, followed by "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 2 trials sponsored, "United Pharmaceuticals" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Belgian Group of Digestive Oncology" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHR Namur" #1 collaborator was "AZ Delta" with 1 trials as a collaborator, "Brugmann University Hospital" with 1 trials as a collaborator, "CHU de Charleroi" with 1 trials as a collaborator, "Centre Hospitalier Universitaire Dinant Godinne - UCL Namur" with 1 trials as a collaborator and "Centre Hospitalier Universitaire Saint Pierre" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "CHR Namur" are "Cow Milk Allergy" (2 trials), "ARF Secondary to COPD Exacerbation" (1 trials), "ARF Secondary to Cardiogenic Acute Pulmonary Oedema" (1 trials), "Advanced Chemorefractory Colorectal Adenocarcinoma" (1 trials) and "Allergy" (1 trials). Many other conditions were trialed in "CHR Namur" in a lesser frequency.

Most popular intervention types in "CHR Namur" are "Drug" (8 trials), "Device" (5 trials), "Dietary Supplement" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "5 FU" (1 trials), "ABSOLUTE™: Self-Expandable Peripheral Nitinol Stent" (1 trials), "Absorbable tack" (1 trials), "Cervical arthroplasty surgery with Granvia-C" (1 trials) and "Extensively Hydrolyzed formula" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHR Namur" are 19 trials for "All" genders.

Currently, there are NaN active trials in "CHR Namur". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in CHR Namur, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CHR Namur, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".